Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovarian Function in PCOS with r-FSH
NCT03252223Phase 4Completed
- Sponsor
- University of California, San Diego
- Start
- Oct 2017
- Primary completion
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of follitropin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by University of California, San Diego. Primary endpoints: Change in granulosa cell function in 24 hours intervals following FSH administration, Change in follicle count following FSH administration at Day 3 and 1 more. Started Oct 2017; status: completed.
02
Drugs
follitropin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03252223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03252223.